324 related articles for article (PubMed ID: 19416781)
1. Safety and efficacy of ibutilide in heart transplant recipients.
Tallaj JA; Franco V; Rayburn BK; Pamboukian SV; Benza RL; Kirklin JK; McGiffin DC; Smallfield M; Bourge RC
J Heart Lung Transplant; 2009 May; 28(5):505-7. PubMed ID: 19416781
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of ibutilide in children and in patients with congenital heart disease.
Hoyer AW; Balaji S
Pacing Clin Electrophysiol; 2007 Aug; 30(8):1003-8. PubMed ID: 17669084
[TBL] [Abstract][Full Text] [Related]
3. Use of ibutilide in cardioversion of patients with atrial fibrillation or atrial flutter treated with class IC agents.
Hongo RH; Themistoclakis S; Raviele A; Bonso A; Rossillo A; Glatter KA; Yang Y; Scheinman MM
J Am Coll Cardiol; 2004 Aug; 44(4):864-8. PubMed ID: 15312873
[TBL] [Abstract][Full Text] [Related]
4. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.
Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE
Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531
[TBL] [Abstract][Full Text] [Related]
5. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
Chiladakis JA; Kalogeropoulos A; Patsouras N; Manolis AS
J Am Coll Cardiol; 2004 Aug; 44(4):859-63. PubMed ID: 15312872
[TBL] [Abstract][Full Text] [Related]
6. [Immediate cardioversion of atrial fibrillation and atrial flutter lasting less than 90 days by ibutilide versus propafenone: a multicenter study].
Zhang HC; Guo JH; Fang Q; Zheng YA; Sun YM; Zhu WQ; Wan Z; Guo JX; Ge JB; Han SM
Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(12):798-801. PubMed ID: 15949393
[TBL] [Abstract][Full Text] [Related]
7. Ibutilide to expedite ED therapy for recent-onset atrial fibrillation flutter.
Mountantonakis SE; Moutzouris DA; Tiu RV; Papaioannou GN; McPherson CA
Am J Emerg Med; 2006 Jul; 24(4):407-12. PubMed ID: 16787796
[TBL] [Abstract][Full Text] [Related]
8. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
Andriushchenko OM; Olesin AI
Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.
Stambler BS; Wood MA; Ellenbogen KA; Perry KT; Wakefield LK; VanderLugt JT
Circulation; 1996 Oct; 94(7):1613-21. PubMed ID: 8840852
[TBL] [Abstract][Full Text] [Related]
10. Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter.
Kafkas NV; Patsilinakos SP; Mertzanos GA; Papageorgiou KI; Chaveles JI; Dagadaki OK; Kelesidis KM
Int J Cardiol; 2007 Jun; 118(3):321-5. PubMed ID: 17049640
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of ibutilide fumarate for the conversion of atrial arrhythmias after cardiac surgery.
VanderLugt JT; Mattioni T; Denker S; Torchiana D; Ahern T; Wakefield LK; Perry KT; Kowey PR
Circulation; 1999 Jul; 100(4):369-75. PubMed ID: 10421596
[TBL] [Abstract][Full Text] [Related]
12. Termination of acute wide QRS complex atrial fibrillation with ibutilide.
Sobel RM; Dhruva NN
Am J Emerg Med; 2000 Jul; 18(4):462-4. PubMed ID: 10919540
[TBL] [Abstract][Full Text] [Related]
13. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.
Tercius AJ; Kluger J; Coleman CI; White CM
Pacing Clin Electrophysiol; 2007 Nov; 30(11):1331-5. PubMed ID: 17976094
[TBL] [Abstract][Full Text] [Related]
14. Ibutilide therapy for atrial fibrillation: 5-year experience in a community hospital.
Giudici MC; Fischer WJ; Cervantes DC; Schrumpf PE; Paul DL; Sentman KE; Serra VL; Barold SS
J Cardiovasc Nurs; 2008; 23(6):484-8. PubMed ID: 18953211
[TBL] [Abstract][Full Text] [Related]
15. Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease.
Cheng A; Dalal D; Fetics BJ; Angkeow P; Spragg DD; Calkins H; Tomaselli GF; Berger RD
J Cardiovasc Electrophysiol; 2009 Aug; 20(8):873-9. PubMed ID: 19460072
[TBL] [Abstract][Full Text] [Related]
16. Ibutilide--a new drug for the rapid termination of atrial fibrillation and atrial flutter.
Kayser SR
Prog Cardiovasc Nurs; 1997; 12(1):39-43. PubMed ID: 9058463
[No Abstract] [Full Text] [Related]
17. Cardioversion of atrial fibrillation with ibutilide in an orthotopic heart transplant patient.
Kaufman LJ; Kofalvi AE; Hong RA; Moreno-Cabral CE; Low LL
J Heart Lung Transplant; 1999 Oct; 18(10):1018-20. PubMed ID: 10561113
[No Abstract] [Full Text] [Related]
18. Brugada syndrome masked by ibutilide treatment in a patient with atrial flutter.
Pagourelias ED; Fragakis N; Koskinas KC; Geleris P
Cardiology; 2012; 122(2):89-92. PubMed ID: 22739533
[TBL] [Abstract][Full Text] [Related]
19. Comparison of intravenous ibutilide vs. propafenone for rapid termination of recent onset atrial fibrillation.
Zhang N; Guo JH; Zhang HCh; Li XB; Zhang P; Xn Y
Int J Clin Pract; 2005 Dec; 59(12):1395-400. PubMed ID: 16351670
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
Honerjäger P; Schmidt G
Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
